NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NovoCure Ltd (NVCR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5153
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer and small cell lung cancer, among others. It also offers provides products for other indications such as glioblastoma and diagnosed glioblastoma, among others. Novocure owns and operates a research centre in Haifa, Israel; and operates along with its subsidiaries located in the US; Berlin, and Germany. The company has its operations in Japan and Switzerland. NovoCure is headquartered in St. Helier, the UK.

NovoCure Ltd (NVCR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NovoCure Ltd, Medical Devices Deals, 2012 to YTD 2018 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NovoCure Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novocure Enters into Agreement with US Oncology Research 11
Novocure Enters into Research Agreement with MD Anderson Cancer Center 12
Equity Offering 13
NovoCure Raises USD95 Million in Public Offering of Series J Shares 13
NovoCure Raises USD194 Million in Public Offering of Series I Shares 14
NovoCure Raises USD55 Million in Public Offering of Series H Shares 15
NovoCure Ltd – Key Competitors 16
NovoCure Ltd – Key Employees 17
NovoCure Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Apr 26, 2018: Novocure Reports First Quarter 2018 Financial Results and Provides Company Update 19
Feb 22, 2018: Novocure Announces Fourth Quarter and Full Year 2017 Financial Results 21
Jan 09, 2018: Novocure Announces Fourth Quarter and Full Year 2017 Operating Statistics and Preliminary Revenue 24
Oct 26, 2017: Novocure Reports Third Quarter 2017 Financial Results and Provides Company Update 25
Jul 27, 2017: Novocure Reports Second Quarter 2017 Financial Results and Provides Company Update 28
Apr 27, 2017: Novocure Reports First Quarter 2017 Financial Results and Provides Company Update 31
Corporate Communications 33
Aug 02, 2018: Novocure announces addition to its Board of Directors 33
May 31, 2018: Novocure Announces Changes to Its Board of Directors 34
May 11, 2017: Martin J. Madden Joins Novocure Board of Directors 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
NovoCure Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
NovoCure Ltd, Medical Devices Deals, 2012 to YTD 2018 9
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novocure Enters into Agreement with US Oncology Research 11
Novocure Enters into Research Agreement with MD Anderson Cancer Center 12
NovoCure Raises USD95 Million in Public Offering of Series J Shares 13
NovoCure Raises USD194 Million in Public Offering of Series I Shares 14
NovoCure Raises USD55 Million in Public Offering of Series H Shares 15
NovoCure Ltd, Key Competitors 16
NovoCure Ltd, Key Employees 17
NovoCure Ltd, Subsidiaries 18

List of Figures
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NovoCure Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NovoCure Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MicroPort Scientific Corp (853)-医療機器分野:企業M&A・提携分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, el …
  • Oncternal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Oncternal Therapeutics Inc (Oncternal) is a clinical-stage oncology company that develops therapies for rare and common cancers. The company’s pipeline compounds include cirmtuzumab and TK216. Its compounds are primarily focused on exciting targets which are uniquely expressed within cancer …
  • Xtract Resources Plc (XTR):企業の財務・戦略的SWOT分析
    Summary Xtract Resources Plc (Xtract Resources), formerly Xtract Energy plc is a mining and mineral exploration and development company that offers mineral resources. The company acquires, explores, manages, operates, produces, mines, extracts, and develops gold and mineral resource deposit properti …
  • PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmAbcine Inc (PharmAbcine) is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers products such as bi-specific MAB and lead MAB products. It provides services such as binding test by ELISA, screening by ELISA, mono-phage Ab seque …
  • Arca Continental SAB de CV:戦略・SWOT・企業財務分析
    Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Arca Continental SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Cyient Ltd (CYIENT):企業の財務・戦略的SWOT分析
    Cyient Ltd (CYIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • LinkedIn Corp:企業の戦略的SWOT分析
    LinkedIn Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Meiji Holdings Co, Ltd.
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Convenience Retail Asia Limited:企業の戦略・SWOT・財務情報
    Convenience Retail Asia Limited - Strategy, SWOT and Corporate Finance Report Summary Convenience Retail Asia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Imaging Dynamics Company Ltd (IDL):医療機器:M&Aディール及び事業提携情報
    Summary Imaging Dynamics Company Ltd (IDC) is a medical device company that offers medical imaging and digital radiography technology solutions. The company provides detector series, proprietary software and DR series products. Its software products include Magellan medical image processing software …
  • Aviva Ltd.:企業の戦略・SWOT・財務分析
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Venture Minerals Ltd (VMS):企業の財務・戦略的SWOT分析
    Summary Venture Minerals Ltd (Venture Minerals) is a mining and mineral exploration and development company that develops, discovers and explores mineral deposits. The company explores for gold, tin, magnetite, copper and tungsten deposits, among others. It provides projects such as Paulsens South p …
  • Alberici Corp:企業の戦略的SWOT分析
    Alberici Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Gree Inc (3632):企業の財務・戦略的SWOT分析
    Gree Inc (3632) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Memorial Resource Development Corp-石油・ガス分野:企業M&A・提携分析
    Summary Memorial Resource Development Corp (Memorial Resource) is an independent natural gas and oil company. It focuses on the exploitation, development, and acquisition of natural gas, natural gas liquids (NGL) and oil properties, primarily in the Cotton Valley formation in North Louisiana. Its pr …
  • Carrefour SA:戦略・SWOT・企業財務分析
    Carrefour SA - Strategy, SWOT and Corporate Finance Report Summary Carrefour SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oleo e Gas Participacoes SA (OGXP3):石油・ガス:M&Aディール及び事業提携情報
    Summary Oleo e Gas Participacoes SA (OGX) is an oil and gas company that acquires and explores for oil and natural gas properties. The company operates a diversified portfolio of exploratory blocks located in offshore sedimentary basins in Brazil. It operates blocks located in onshore sedimentary ba …
  • Mimetogen Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Mimetogen Pharmaceuticals Inc (Mimetogen) is a clinical stage biotechnology company that develops the use of peptidomimetics for the treatment of ophthalmic diseases. The company’s lead compound, MIM-D3, which is in Phase 3 clinical study used for the treatment of dry eye syndrome. It also o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆